Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
3.080
+0.090 (3.01%)
At close: Oct 23, 2026, 4:00 PM EDT
3.098
+0.018 (0.58%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $5.09 million as of October 23, 2026. It is the 44,795th most valuable company in the world and the 5,988th biggest in the United States. Its market cap has decreased by 71.57% in one year.
Market Cap
5.09M
Enterprise Value
1.56M
1-Year Change
-71.57%
Global Rank
Country Rank
#5,988 United States
Category
ChartMarket Cap Chart
Since January 12, 2021, Lexaria Bioscience's market cap has decreased from $18.20M to $5.09M, a decrease of -72.03%. That is a compound annual growth rate of -19.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 5.09M | -62.85% |
| Dec 31, 2025 | 13.70M | -62.67% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 26.92% |
| Jan 12, 2021 | 18.20M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 5.79M |
| Evogene | 5.76M |
| Alzamend Neuro | 5.45M |
| Pulmatrix | 5.41M |
| Niki BioSolutions | 5.38M |
| Traws Pharma | 5.26M |
| Longeveron | 5.10M |
| Cardio Diagnostics Holdings | 5.00M |